0001127602-11-017500.txt : 20110525
0001127602-11-017500.hdr.sgml : 20110525
20110525161803
ACCESSION NUMBER: 0001127602-11-017500
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110523
FILED AS OF DATE: 20110525
DATE AS OF CHANGE: 20110525
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HAGEMANN ROBERT
CENTRAL INDEX KEY: 0001222676
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 11871149
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
4
1
form4.xml
PRIMARY DOCUMENT
X0303
4
2011-05-23
0001022079
QUEST DIAGNOSTICS INC
DGX
0001222676
HAGEMANN ROBERT
C/O QUEST DIAGNOSTICS INCORPORATED
3 GIRALDA FARMS
MADISON
NJ
07940
1
SVP & Chief Financial Officer
Common Stock
2011-05-23
4
M
0
1650
35.5325
A
141302
D
Common Stock
2011-05-23
4
S
0
1650
57.4803
D
139652
D
Common Stock
2011-05-23
4
M
0
2500
48.74
A
142152
D
Common Stock
2011-05-23
4
S
0
2500
57.4456
D
139652
D
Common Stock
1760
I
SDCP
Stock Options (Right to Buy)
35.5325
2011-05-23
4
M
0
1650
0
D
2012-02-27
Common Stock
1650
23100
D
Stock Options (Right to Buy)
48.74
2011-05-23
4
M
0
2500
0
D
2012-02-22
Common Stock
2500
35000
D
This exercise and sale reported were effected pursuant to Rule 10b-5-1 sales plan adopted by the reporting person on February 7, 2011.
The options vested in three installments on April 17, 2003, February 27, 2004 and February 27, 2005.
The options vested in three annual installments on February 22, 2006, February 22, 2007 and February 22, 2008.
This transaction was executed in multiple trades at prices ranging from $57.35 to $57.575. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $57.34 to $57.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The amount includes exempt purchases made under the Company's stock purchase plan.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company stock as of that date.
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Robert Hagemann
2011-05-25